Titre : Oxystérols

Oxystérols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Infant Behavior
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Oxystérols : Questions médicales les plus fréquentes", "headline": "Oxystérols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Oxystérols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-17", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Oxystérols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cholestérol", "url": "https://questionsmedicales.fr/mesh/D002784", "about": { "@type": "MedicalCondition", "name": "Cholestérol", "code": { "@type": "MedicalCode", "code": "D002784", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.938.208" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hydroxycholestérols", "alternateName": "Hydroxycholesterols", "url": "https://questionsmedicales.fr/mesh/D006888", "about": { "@type": "MedicalCondition", "name": "Hydroxycholestérols", "code": { "@type": "MedicalCode", "code": "D006888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.938.208.825.500" } } }, { "@type": "MedicalWebPage", "name": "Cétocholestérols", "alternateName": "Ketocholesterols", "url": "https://questionsmedicales.fr/mesh/D007653", "about": { "@type": "MedicalCondition", "name": "Cétocholestérols", "code": { "@type": "MedicalCode", "code": "D007653", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.938.208.825.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Oxystérols", "alternateName": "Oxysterols", "code": { "@type": "MedicalCode", "code": "D000072376", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yuqin Wang", "url": "https://questionsmedicales.fr/author/Yuqin%20Wang", "affiliation": { "@type": "Organization", "name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. y.wang@swansea.ac.uk." } }, { "@type": "Person", "name": "William J Griffiths", "url": "https://questionsmedicales.fr/author/William%20J%20Griffiths", "affiliation": { "@type": "Organization", "name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. w.j.griffiths@swansea.ac.uk." } }, { "@type": "Person", "name": "Caroline Pot", "url": "https://questionsmedicales.fr/author/Caroline%20Pot", "affiliation": { "@type": "Organization", "name": "Laboratories of Neuroimmunology, Neuroscience Research Center and Division of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and Lausanne University, Chemin des Boveresses 155, 1066 Epalinges, Switzerland. Caroline.Pot-Kreis@chuv.ch." } }, { "@type": "Person", "name": "Gérard Lizard", "url": "https://questionsmedicales.fr/author/G%C3%A9rard%20Lizard", "affiliation": { "@type": "Organization", "name": "Team \"Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism\" EA 7270/Inserm, University Bourgogne Franche-Comté, Dijon, France." } }, { "@type": "Person", "name": "Eylan Yutuc", "url": "https://questionsmedicales.fr/author/Eylan%20Yutuc", "affiliation": { "@type": "Organization", "name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. eylan.yutuc@swansea.ac.uk." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Respiratory distress in small for gestational age infants based on local newborn curve prior to hospital discharge.", "datePublished": "2022-09-30", "url": "https://questionsmedicales.fr/article/36245714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fped.2022.986695" } }, { "@type": "ScholarlyArticle", "name": "Relationship between bronchopulmonary dysplasia phenotypes with high-resolution computed tomography score in early preterm infants.", "datePublished": "2022-09-20", "url": "https://questionsmedicales.fr/article/36204662", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fped.2022.935733" } }, { "@type": "ScholarlyArticle", "name": "Changes in Etiology of Invasive Bacterial Infections in Infants Under 3 Months of Age in Korea, 2006-2020.", "datePublished": "2022-09-20", "url": "https://questionsmedicales.fr/article/36375095", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/INF.0000000000003714" } }, { "@type": "ScholarlyArticle", "name": "Association between adherence to the dietary approaches to stop hypertension (DASH) diet and maternal and infant sleep disorders.", "datePublished": "2022-09-19", "url": "https://questionsmedicales.fr/article/36123718", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40795-022-00600-0" } }, { "@type": "ScholarlyArticle", "name": "Effects of Play in an Upright Position on Intra-Individual Variability of Gross Motor and Language Development in Institutionalized Infants.", "datePublished": "2022-09-19", "url": "https://questionsmedicales.fr/article/36142086", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph191811804" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Stérols", "item": "https://questionsmedicales.fr/mesh/D013261" }, { "@type": "ListItem", "position": 5, "name": "Cholestérol", "item": "https://questionsmedicales.fr/mesh/D002784" }, { "@type": "ListItem", "position": 6, "name": "Oxystérols", "item": "https://questionsmedicales.fr/mesh/D000072376" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Oxystérols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Oxystérols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Oxystérols", "description": "Comment diagnostiquer une dysfonction liée aux oxystérols ?\nQuels tests sont utilisés pour mesurer les oxystérols ?\nLes symptômes peuvent-ils indiquer un excès d'oxystérols ?\nY a-t-il des biomarqueurs pour les oxystérols ?\nComment les oxystérols sont-ils liés aux maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Oxystérols", "description": "Quels sont les symptômes d'une accumulation d'oxystérols ?\nLes oxystérols peuvent-ils affecter le système nerveux ?\nY a-t-il des signes cutanés liés aux oxystérols ?\nComment les oxystérols influencent-ils le métabolisme ?\nPeut-on ressentir des douleurs musculaires avec des oxystérols élevés ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Oxystérols", "description": "Comment prévenir les troubles liés aux oxystérols ?\nLe contrôle du poids aide-t-il à prévenir les problèmes d'oxystérols ?\nLes examens réguliers sont-ils importants pour les oxystérols ?\nL'exercice physique influence-t-il les niveaux d'oxystérols ?\nLes habitudes alimentaires peuvent-elles prévenir les troubles d'oxystérols ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Oxystérols", "description": "Quels traitements existent pour les troubles liés aux oxystérols ?\nLes statines sont-elles efficaces contre les oxystérols ?\nY a-t-il des thérapies ciblées pour les oxystérols ?\nComment la diététique aide-t-elle à gérer les oxystérols ?\nLes suppléments peuvent-ils aider à réguler les oxystérols ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Oxystérols", "description": "Quelles complications peuvent survenir avec des oxystérols élevés ?\nLes oxystérols sont-ils liés à des maladies hépatiques ?\nPeut-on développer un diabète avec des oxystérols anormaux ?\nLes troubles cognitifs sont-ils liés aux oxystérols ?\nLes oxystérols peuvent-ils affecter la santé osseuse ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Oxystérols", "description": "Quels sont les facteurs de risque pour les troubles d'oxystérols ?\nL'hérédité joue-t-elle un rôle dans les troubles d'oxystérols ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe tabagisme influence-t-il les niveaux d'oxystérols ?\nLe stress peut-il affecter les niveaux d'oxystérols ?", "url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Infant+Behavior&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction liée aux oxystérols ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins mesurant les niveaux d'oxystérols." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer les oxystérols ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang spécifiques, comme la chromatographie, sont utilisées." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un excès d'oxystérols ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue ou des troubles neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs pour les oxystérols ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains oxystérols peuvent servir de biomarqueurs dans des pathologies spécifiques." } }, { "@type": "Question", "name": "Comment les oxystérols sont-ils liés aux maladies cardiovasculaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés d'oxystérols sont associés à un risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une accumulation d'oxystérols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs abdominales et troubles neurologiques." } }, { "@type": "Question", "name": "Les oxystérols peuvent-ils affecter le système nerveux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés liés aux oxystérols ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées ou des anomalies peuvent survenir en cas d'accumulation." } }, { "@type": "Question", "name": "Comment les oxystérols influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils régulent le métabolisme lipidique, affectant le stockage et l'utilisation des graisses." } }, { "@type": "Question", "name": "Peut-on ressentir des douleurs musculaires avec des oxystérols élevés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent être un symptôme d'une dysfonction lipidique." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux oxystérols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et un mode de vie actif sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Le contrôle du poids aide-t-il à prévenir les problèmes d'oxystérols ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé peut réduire le risque de troubles liés aux oxystérols." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants pour les oxystérols ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans de santé réguliers aident à détecter les anomalies précocement." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il les niveaux d'oxystérols ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut aider à réguler les niveaux d'oxystérols dans le sang." } }, { "@type": "Question", "name": "Les habitudes alimentaires peuvent-elles prévenir les troubles d'oxystérols ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fibres et faible en graisses saturées est bénéfique." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux oxystérols ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des modifications diététiques et des médicaments hypolipémiants." } }, { "@type": "Question", "name": "Les statines sont-elles efficaces contre les oxystérols ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les statines peuvent aider à réduire les niveaux d'oxystérols dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des thérapies ciblées pour les oxystérols ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées sont en développement pour traiter les dysfonctionnements liés." } }, { "@type": "Question", "name": "Comment la diététique aide-t-elle à gérer les oxystérols ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire les niveaux d'oxystérols et améliorer la santé." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils aider à réguler les oxystérols ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les oméga-3, peuvent aider à équilibrer les lipides." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des oxystérols élevés ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des maladies cardiovasculaires et des troubles neurologiques." } }, { "@type": "Question", "name": "Les oxystérols sont-ils liés à des maladies hépatiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent contribuer à des maladies du foie et à la stéatose." } }, { "@type": "Question", "name": "Peut-on développer un diabète avec des oxystérols anormaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux d'oxystérols anormaux peuvent augmenter le risque de diabète." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils liés aux oxystérols ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent être associés à des troubles cognitifs et à la démence." } }, { "@type": "Question", "name": "Les oxystérols peuvent-ils affecter la santé osseuse ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent influencer la santé osseuse et le risque de fractures." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles d'oxystérols ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, une alimentation riche en graisses et le diabète." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles d'oxystérols ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de dyslipidémies augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire contribue à des niveaux élevés d'oxystérols." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les niveaux d'oxystérols ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les dysfonctionnements lipidiques et les niveaux d'oxystérols." } }, { "@type": "Question", "name": "Le stress peut-il affecter les niveaux d'oxystérols ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber le métabolisme lipidique et augmenter les oxystérols." } } ] } ] }

Sources (10000 au total)

Respiratory distress in small for gestational age infants based on local newborn curve prior to hospital discharge.

Respiratory distress in newborns, which may lead to risks of morbidity and death, is one of the reasons for a referral to the more advanced health facilities. Respiratory distress analysis in small fo... To identify the risks, complications, death induced by respiratory distress in SGA infants prior to hospital discharge.... A retrospective cohort study was conducted on live- born infants at Sardjito Hospital. Singleton and gestational age 26-42 weeks were the inclusion criteria. The exclusion criteria included major cong... There were 12,490 infants eligible for the study, consisting of 9,396 FT-AGA infants, 2,003 PT-AGA infants, 771 FT-SGA infants, and 320 PT-SGA infants. Nine hundred and thirty-two infants developed re... PT-SGA had the highest risk of respiratory distress with complications of length of hospital stay, and ventilator use. Mortality analysis discovered the highest CMI in PT-SGA infants. We should theref...

Relationship between bronchopulmonary dysplasia phenotypes with high-resolution computed tomography score in early preterm infants.

To assess the relationship between high-resolution computed tomography (HRCT) abnormalities and clinical phenotypes of bronchopulmonary dysplasia (BPD).... A retrospective, single-center study was carried out at the Children's Hospital of Fudan University between 2013 and 2020. Preterm infants born at ≤ 32 weeks' gestation who were diagnosed with BPD and... A total of 81 cases were included in the study. Cases with more severe BPD had a higher TS (... HRCT scores correlated with BPD severity and PH in our study. HS might be a useful tool in the assessment of BPD severity while linear densities and consolidation might be helpful in predicting PH....

Changes in Etiology of Invasive Bacterial Infections in Infants Under 3 Months of Age in Korea, 2006-2020.

Invasive bacterial infection (IBI) causes a significant burden in infants. In this study, we analyzed changes in epidemiology of IBI among infants in Korea.... A retrospective multicenter-based surveillance for IBIs in infants <3 months of age was performed during 2006-2020. Cases were classified as an early-onset disease (EOD) (0-6 days) or late-onset disea... Among 1545 cases, the median age was 28 days (IQR: 12, 53) and EOD accounted for 17.7%. Among pathogens, S. agalactiae (40.4%), E. coli (38.5%), and S. aureus (17.8%) were the most common and attribut... During 2006-2020, among IBI in infants <3 months of age, S. agalactiae, E. coli, and S. aureus were most common and an increasing trend of S. agalactiae was observed....

Association between adherence to the dietary approaches to stop hypertension (DASH) diet and maternal and infant sleep disorders.

Maternal diet is known to be important to both mother and infant health. The purpose of this study was to evaluate the association between adherence to the Dietary Approaches to Stop Hypertension (DAS... The study included 350 breastfeeding mothers with an average age of 29.5 ± 5.9 years. Psychological functions were performed using standard questionnaires, including a Quality-of-Life Questionnaire (Q... Subjects in the highest tertile of DASH DP had significantly lower scores of mother's sleep latency (0.70 ± 1.18 vs. 1.24 ± 1.3; P value = 0.031), sleep disorders (4.3 ± 1.6 vs. 5.3 ± 2.4; P value= 0.... According to our findings, adherence to DASH DP is associated with a lower score for sleep disorders in mothers and their infants....

Inhaled Nitric Oxide Therapy in the Post-Acute Phase in Extremely Preterm Infants: A Japanese Cohort Study.

To determine the trends in inhaled nitric oxide (iNO) utilization in the late phase of hospitalization in a large Japanese cohort of extremely preterm infants and evaluate its benefit on long-term out... This was a retrospective multicenter cohort study of 15 977 extremely preterm infants born at <28 weeks of gestational age between 2003 and 2016, in the Neonatal Research Network, Japan. Demographic c... Post-acute iNO utilization rates increased from 0.3% in 2009 to 1.9% in 2016, even under strict insurance coverage rules starting in 2009. Gestational age (1-week increment; aOR 0.82, 95% CI 0.76-0.88... The increasing post-acute iNO utilization rate among extremely preterm infants has been concurrent with improved survival rates of extremely preterm infants in Japan. Infants treated with post-acute i...

Successful Haploidentical Bone Marrow Transplantation of an Infant With a Novel Mutation in SAMD9L Gene (Ataxia-Pancytopenia Syndrome).

Data regarding the outcomes of hematopoietic stem cell transplant (HSCT) for the management of SAMD9L -associated ataxia-pancytopenia syndrome remains limited. We depict the case of a 2-month-old male...

Early Life Determinants of Vascular Structure in Fetuses, Infants, Children, and Adolescents: A Systematic Review and Meta-Analysis.

To investigate the association between early life exposures during the first 1000 days (conception to age 24 months) and aortic intima-media thickness (aIMT), an early indicator of cardiovascular dise... The MEDLINE, Embase, Scopus, CINAHL, and Allied and Complementary Medicine databases were searched from inception to July 2021. Eligibility criteria included observational controlled studies in youths... A total of 8657 articles were identified, of which 34 were included in our meta-analysis. The age of participants ranged from 22.9 weeks gestation in utero to 10.9 years. In the meta-analysis (n = 122... Adverse early life exposures are associated with greater aIMT in youths, consistent with an increased risk for CVD later in life. Further research is needed to determine whether intervention and preve...

Incidence of infant mortality and its predictors in East Africa using Gompertz gamma shared frailty model.

Globally, infant mortality is a major public health concern and a sensitive indicator of countries' socio-economic and health status. Despite the substantial reduction of under-five mortality in sub-S... The present study has utilized 138,803 weighted samples from Demographic and Health Surveys (DHSs) of 12 East African countries. Considering the hierarchical nature of DHS data shared frailty parametr... The infant mortality rate in East Africa was 41.41 per 1000 live births. Mothers aged 25-34 years, wanted birth, health facility delivery, 1-3 ANC visit, being 2... Despite the substantial progress in improving maternal and child health, this study showed that infant mortality is still a major public health concern in East Africa. Maternal age, place of delivery,...